Veracyte (VCYT) Amortization of Deferred Charges (2013 - 2019)

Veracyte has disclosed Amortization of Deferred Charges across 7 years of filings, most recently posting $75000.0 for Q2 2019.

• Amortization of Deferred Charges for Q2 2019 came in at $75000.0, up 837.5% year-over-year; the trailing twelve-month figure through Mar 2020 was $75000.0 (up 134.38% YoY), and the FY2019 annual result was $83000.0, up 159.38% from the prior year.
• Amortization of Deferred Charges came in at $75000.0 for Q2 2019 at Veracyte, up from $8000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $393000.0 in Q4 2017 to a low of -$477000.0 in Q4 2016.
• The 5-year median for Amortization of Deferred Charges is $19000.0 (2015), against an average of $96388.9.
• Peak annual rise in Amortization of Deferred Charges reached 3108.33% in 2016, while the deepest fall reached 1136.96% in 2016.
• Veracyte's Amortization of Deferred Charges stood at $46000.0 in 2015, then sank by 1136.96% to -$477000.0 in 2016, then soared by 182.39% to $393000.0 in 2017, then tumbled by 97.96% to $8000.0 in 2018, then jumped by 837.5% to $75000.0 in 2019.
• The last three Amortization of Deferred Charges figures came in at $75000.0 (Q2 2019), $8000.0 (Q1 2019), and $8000.0 (Q4 2018), per Business Quant data.